Two Recessions Couldn’t Stop These 4 Healthcare Stocks From Raising Dividends
Four healthcare stocks—JNJ, ABT, MDT, and BDX—raised dividends through two recessions. JNJ (JNJ, $266.60, 1.97% yield) has a 64-year streak and $21B FCF. MDT (MDT, $90.83, 3.16% yield) leads in yield with 49 years of raises. ABT (ABT, $110.10, 2.22% yield) has 54 years of raises. BDX (BDX, $188.67, 2.23% yield) grew FCF 45% YTD. All benefit from inelastic demand for healthcare products.
How this was made
The 30-second read
Why it matters
While dividend hikes improve yield, they are unlikely to trigger large price moves; the primary impact is on income‑focused allocation decisions.
Market read
The dividend announcements reinforce the defensive positioning of large‑cap healthcare stocks, likely attracting income investors amid uncertain macro conditions.
What to watch
Potential headwinds from biosimilar competition and segment-specific risks could limit upside.
Background
The article reviews four major U.S. healthcare companies that have consistently raised dividends through past recessions, emphasizing their cash flow strength and defensive appeal.
Ticker impact
Johnson & Johnson announced its quarterly dividend increase to $1.34, continuing a 64‑year raise streak.
small upside as yield improves
Dividend increase signals strong cash flow; market may price in modest rally.
Abbott Laboratories raised its quarterly payout to $0.63, marking 54 consecutive years of dividend increases.
stable to slight rise
Consistent dividend growth supports income demand; no major catalyst beyond payout.
Medtronic increased its quarterly dividend to $0.72, extending a 49‑year streak of raises.
minor upside
Higher yield aligns with strong free cash flow; market reaction likely muted.
Becton, Dickinson raised its quarterly dividend to $1.05, continuing a decade‑long increase series.
stable to slight rise
Steady cash generation and higher payout may attract income investors without major volatility.
Market effects
Highlights resilience of healthcare dividend stocks during economic downturns.
U.S. healthcare sector may see modest inflows from income‑seeking investors.
Reinforces perception of healthcare as defensive asset class worldwide.
Counterpoint
Dividend raises may mask underlying growth challenges; focus on earnings growth instead.
Key entities
- CompanyJohnson & Johnson
Healthcare conglomerate with 64‑year dividend raise streak.
- CompanyAbbott Laboratories
Diagnostic and nutrition firm with 54‑year dividend streak.
- CompanyMedtronic
Medical device maker with 49‑year dividend streak.
- CompanyBecton, Dickinson
Medical supplies company with recent dividend increase.
